Unplanned readmissions in younger and older adult patients: the role of healthcare-related adverse events

Table 3 Types of AE categories in readmission and no readmission group

Study population	All individuals				Younger individuals (<65 years)			Older individuals (≥65 years)
N (%) or median (range)	Total study population	Readmission group	No readmission group	p value*	Readmission group	No readmission group	p value*	Readmission group	No readmission group	p value*
N (%) or median (range)	N = 333	N = 65 (19.5)	N = 268 (80.5)	p value*	N = 33 (21.0)	N = 124 (79.0)	p value*	N = 32 (18.2)	N = 144 (81.8)	p value*
Type of AE as reason for index admission
Medication-related	179 (53.8)	27 (41.5)	152 (56.7)	0.03	10 (30.3)	61 (49.2)	0.05	17 (53.1)	91 (63.2)	0.29
Chemotherapy-related	74 (22.2)	21 (32.3)	53 (19.8)	0.03	15 (45.5)	33 (26.6)	0.04	6 (18.8)	20 (13.9)	0.58
Procedure-related	50 (15.0)	15 (23.1)	34 (13.1)	0.04	7 (21.2)	15 (12.1)	0.18	8 (25.0)	20 (13.9)	0.18
Diabetes mellitus-related	29 (8.7)	2 (3.1)	27 (10.1)	0.09	1 (3.0)	15 (12.1)	0.13	1 (3.1)	12 (8.3)	0.47
Other	1 (0.3)	0	1 (0.4)	1.0	0	0	NA	0	1 (0.7)	1.0

Numbers in italic show significant differences
AE adverse event
* p values are given for statistical test between the readmission and no readmission groups

ISSN: 2047-783X